BOSTON, MA January 30, 2017 – New England Eye Center Glaucoma specialists are now offering a new minimally invasive surgical treatment for mild to moderate primary open-angle glaucoma. The CyPass Micro-Stent device was recently approved by the FDA for use in conjunction with cataract surgery. Research studies demonstrated a significant and lasting reduction in intraocular pressure and glaucoma medications for many patients. This device is considered a major advancement in Glaucoma treatment, and may avoid some of the complications of other types of surgical treatment.
NEEC doctors are already experienced with the Cypass Micro-Stent, having been involved with the research studies on this device. The small implant is placed inside the eye during cataract surgery. The Micro-stent is designed to lower intraocular pressure (IOP) by enhancing aqueous fluid outflow through one of the natural drainage pathways of the eye, with minimal tissue disruption.
New England Eye Center (NEEC) is the ophthalmology department for Tufts Medical Center and Tufts University School of Medicine. New England Eye Center offers a full range of comprehensive ophthalmology including treatments for cataracts, glaucoma, macular degeneration, pediatric ophthalmology and aesthetic surgery. New England Eye Center is also a leading provider of Laser Vision Correction in Greater Boston and New England offering a full range of vision correction procedures for all types of eye conditions.
# # #
Cynthia Mattox, MD